Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCytomX Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

CytomX Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

Loading earnings…

$2.94Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
QuarterRevenue YoYGross marginCash & equivalents
QuarterRevenue YoYGross marginCash & equivalents
(Filed on August 6, 2026)
-92.4%100.0%$17.2M

Filing text is unavailable for this period.

(Filed on May 7, 2026)
-79.9%100.0%$28.8M

Filing text is unavailable for this period.

(Filed on March 16, 2026)
-98.3%100.0%$12.7M

Filing text is unavailable for this period.

(Filed on November 6, 2025)
-82.2%100.0%$34.2M

Filing text is unavailable for this period.

(Filed on August 6, 2026)
-25.7%100.0%$49M
(Filed on May 7, 2026)
+22.8%100.0%$47.6M
(Filed on March 16, 2026)
+43.2%100.0%$38.1M
(Filed on November 6, 2025)
+26.7%100.0%$40.6M
(Filed on August 7, 2025)
+1.6%100.0%$43.2M
(Filed on May 12, 2025)
+76.4%100.0%$36.2M
(Filed on March 6, 2025)
+32.2%100.0%$17.2M
(Filed on November 7, 2024)
+136.7%100.0%$26M
(Filed on August 8, 2024)
+92.4%100.0%$57.5M
(Filed on May 8, 2024)
+159.9%100.0%$56.4M
(Filed on March 11, 2024)
+80.8%100.0%$193.7M
(Filed on November 7, 2023)
+21.3%100.0%$95M
(Filed on August 8, 2023)
+46.1%100.0%$129.3M
(Filed on May 9, 2023)
-43.4%100.0%$163.5M
(Filed on March 27, 2023)
(Filed on March 27, 2023)
+57.3%100.0%$205.5M
(Filed on November 8, 2022)
+23.1%100.0%$236.3M
(Filed on August 4, 2022)
+25.9%100.0%$256.1M
(Filed on May 5, 2022)
(Filed on May 6, 2021)
-67.8%100.0%$329.7M
(Filed on March 27, 2023)
(Filed on March 1, 2022)
+131.7%100.0%$191.9M
(Filed on November 4, 2021)
-30.3%100.0%$176.8M
(Filed on August 5, 2021)
-22.5%100.0%$291.4M
(Filed on May 6, 2021)
+68.2%100.0%$143.3M
(Filed on March 27, 2023)
(Filed on February 24, 2021)
-294.5%100.0%$188.4M
(Filed on November 5, 2020)
-14.4%100.0%$164.6M
(Filed on August 6, 2020)
-57.8%100.0%$149.4M
(Filed on May 7, 2020)
+107.9%100.0%$190.4M
(Filed on February 27, 2020)
-57.6%100.0%$247.6M
(Filed on November 7, 2019)
-48.2%100.0%$259.8M
(Filed on August 7, 2019)
+143.8%100.0%$132.9M
(Filed on May 9, 2019)
+21.7%100.0%$142.2M
(Filed on February 27, 2019)
+331.6%100.0%$177.5M
(Filed on November 6, 2018)
+599.0%100.0%$284.2M
(Filed on August 8, 2018)
+182.9%100.0%$272.9M
(Filed on May 9, 2018)
+424.2%100.0%$85.7M
(Filed on March 7, 2018)
+215.5%100.0%$104.6M
(Filed on November 7, 2017)
+78.1%100.0%$59.8M
(Filed on August 7, 2017)
+51.4%100.0%$62.4M
(Filed on May 5, 2017)
+27.6%100.0%$67.9M
(Filed on March 2, 2017)
+6.8%100.0%$59.8M
(Filed on November 3, 2016)
+1.3%100.0%$36.2M
(Filed on August 3, 2016)
—100.0%—
(Filed on May 6, 2016)
—100.0%—
(Filed on March 7, 2016)
—100.0%$64.4M
(Filed on November 23, 2015)
—100.0%—